UBS analyst Jay Sole raised the firm’s price target on Crocs (CROX) to $132 from $122 and keeps a Neutral rating on the shares. The Q4 earnings report was moderately better than expected, but UBS still views Crocs as a low growth stock with just a 1% five-year EPS compound annual growth rate, the analyst tells investors in a research note. The firm doesn’t see a catalyst to drive the stock’s multiple higher.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CROX:
